此页面是自动翻译的,不保证翻译的准确性。请参阅 英文版 对于源文本。

Comparison of Low-Dose Versus Standard-Dose Hyperbaric Bupivacaine in Spinal Anesthesia

2026年7月10日 更新者:Muhammad Shaheryar Bashir、Mayo Hospital Lahore

Comparison of Low-Dose Versus Standard-Dose Hyperbaric Bupivacaine in Spinal Anesthesia: Hemodynamic Stability and Recovery Profile in Elderly Patients Undergoing Lower Limb Orthopedic Surgery

The goal of this randomized controlled trial is to determine whether low-dose hyperbaric bupivacaine provides better hemodynamic stability and postoperative recovery compared with standard-dose hyperbaric bupivacaine in elderly patients undergoing lower limb orthopedic surgery under spinal anesthesia.

The main questions it aims to answer are:

  • Does low-dose hyperbaric bupivacaine reduce the incidence of intraoperative hypotension and bradycardia compared with standard-dose hyperbaric bupivacaine?
  • Does low-dose hyperbaric bupivacaine improve postoperative recovery profile compared with standard-dose hyperbaric bupivacaine?

Researchers will compare elderly patients receiving low-dose hyperbaric bupivacaine with those receiving standard-dose hyperbaric bupivacaine to determine whether a lower intrathecal dose improves cardiovascular stability and recovery without compromising the effectiveness of spinal anesthesia.

Participants will:

  • Provide written informed consent before enrollment.
  • Undergo elective lower limb orthopedic surgery under spinal anesthesia.
  • Be randomly assigned to receive either low-dose or standard-dose hyperbaric bupivacaine.
  • Have their blood pressure, heart rate, and other vital signs monitored throughout the surgical procedure.
  • Be assessed for intraoperative hypotension and bradycardia according to predefined study criteria.
  • Be evaluated for postoperative recovery parameters, including motor recovery and readiness for postoperative recovery and mobilization.

The information obtained from this study may help identify a safer and more effective spinal anesthetic technique for elderly patients undergoing orthopedic surgery.

研究概览

研究类型

介入性

注册 (估计的)

180

阶段

  • 第四阶段

联系人和位置

本节提供了进行研究的人员的详细联系信息,以及有关进行该研究的地点的信息。

学习联系方式

  • 姓名:Muhammad Shaheryar Bashir, MBBS, BSc, FCPS (R) CHPE, DPHN
  • 电话号码:+92-335-4377900
  • 邮箱:drmsb259@gmail.com

学习地点

    • Punjab Province
      • Lahore、Punjab Province、巴基斯坦、54950
        • Mayo Hospital, Lahore

参与标准

研究人员寻找符合特定描述的人,称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。

资格标准

适合学习的年龄

  • 年长者

接受健康志愿者

不

描述

Inclusion Criteria:

  • Male or female patients aged 65 years and above.
  • Patients scheduled for elective lower limb orthopedic surgery under spinal anesthesia.
  • American Society of Anesthesiologists (ASA) physical status I-III.
  • Patients willing to participate and provide written informed consent.

Exclusion Criteria:

  • Refusal to participate in the study.
  • Contraindications to spinal anesthesia (e.g., infection at puncture site, coagulopathy, severe hypovolemia, raised intracranial pressure).
  • Known hypersensitivity or allergy to bupivacaine.
  • Severe valvular heart disease.
  • Significant cardiac arrhythmias.
  • Uncontrolled hypertension.
  • Severe hepatic or renal impairment.
  • Pre-existing neurological disorders affecting lower limb motor or sensory function.
  • Severe spinal deformity or previous lumbar spine surgery interfering with spinal anesthesia.
  • Cognitive impairment or inability to provide informed consent.
  • Emergency orthopedic procedures.

学习计划

本节提供研究计划的详细信息,包括研究的设计方式和研究的衡量标准。

研究是如何设计的?

设计细节

  • 主要用途:治疗
  • 分配:随机化
  • 介入模型:并行分配
  • 屏蔽:双倍的

武器和干预

参与者组/臂
干预/治疗
实验性的:Low-Dose Hyperbaric Bupivacaine
Participants randomized to this group will receive low-dose hyperbaric bupivacaine for spinal anesthesia before elective lower limb orthopedic surgery. Hemodynamic parameters and postoperative recovery outcomes will be assessed according to the study protocol.
Low-dose hyperbaric bupivacaine administered intrathecally for spinal anesthesia in elderly patients undergoing elective lower limb orthopedic surgery.
有源比较器:Standard-Dose Hyperbaric Bupivacaine
Participants randomized to this group will receive standard-dose hyperbaric bupivacaine for spinal anesthesia before elective lower limb orthopedic surgery. Hemodynamic parameters and postoperative recovery outcomes will be assessed according to the study protocol.
Standard-dose hyperbaric bupivacaine administered intrathecally for spinal anesthesia in elderly patients undergoing elective lower limb orthopedic surgery.

研究衡量的是什么?

主要结果指标

结果测量
措施说明
大体时间
Incidence of Intraoperative Hypotension
大体时间:From administration of spinal anesthesia until completion of surgery
Occurrence of intraoperative hypotension following spinal anesthesia, defined as a decrease in systolic blood pressure greater than 20% from baseline or systolic blood pressure less than 90 mmHg requiring intervention.
From administration of spinal anesthesia until completion of surgery

次要结果测量

结果测量
措施说明
大体时间
Incidence of Intraoperative Bradycardia
大体时间:From administration of spinal anesthesia until completion of surgery.
Occurrence of intraoperative bradycardia, defined as heart rate less than 50 beats per minute requiring pharmacological treatment.
From administration of spinal anesthesia until completion of surgery.
Time to Complete Motor Recovery
大体时间:From completion of surgery until achievement of Bromage Score 0, assessed up to 24 hours postoperatively
Time required to achieve complete motor recovery following spinal anesthesia, assessed using Bromage Score 0.
From completion of surgery until achievement of Bromage Score 0, assessed up to 24 hours postoperatively
Time to First Ambulation
大体时间:Within the first 24 hours after surgery
Time from completion of surgery to the patient's first assisted ambulation.
Within the first 24 hours after surgery
Postoperative Recovery Profile
大体时间:From completion of surgery until discharge from the post-anesthesia care unit (PACU), assessed up to 24 hours postoperatively
Assessment of recovery following spinal anesthesia, including readiness for discharge from the post-anesthesia care unit and return of motor function.
From completion of surgery until discharge from the post-anesthesia care unit (PACU), assessed up to 24 hours postoperatively

合作者和调查者

在这里您可以找到参与这项研究的人员和组织。

出版物和有用的链接

负责输入研究信息的人员自愿提供这些出版物。这些可能与研究有关。

一般刊物

研究记录日期

这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查,以确保它们在发布到公共网站之前符合特定的质量控制标准。

研究主要日期

学习开始 (估计的)

2026年7月1日

初级完成 (估计的)

2027年6月30日

研究完成 (估计的)

2027年6月30日

研究注册日期

首次提交

2026年6月24日

首先提交符合 QC 标准的

2026年6月29日

首次发布 (实际的)

2026年7月6日

研究记录更新

最后更新发布 (实际的)

2026年7月13日

上次提交的符合 QC 标准的更新

2026年7月10日

最后验证

2026年7月1日

更多信息

与本研究相关的术语

计划个人参与者数据 (IPD)

计划共享个人参与者数据 (IPD)?

不

IPD 计划说明

Individual participant data (IPD) collected during this study will not be made publicly available. Participant confidentiality and privacy will be maintained in accordance with institutional ethical guidelines and the approved study protocol. Aggregate study results may be published or presented, but individual-level data will not be shared outside the research team.

药物和器械信息、研究文件

研究美国 FDA 监管的药品

不

研究美国 FDA 监管的设备产品

不

在美国制造并从美国出口的产品

不

此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.

订阅